Kendall, Tim, McGoey, Linsey and Jackson, Emily (2009) If NICE was in the USA. The Lancet, 374 (9686). pp. 272-273.
Decisions about drugs by doctors, patients, and the public depend on a complex framework of industry regulation, professional and public guidance, and transparent publication of the research on which the regulatory framework depends. In the UK, there are two agencies with a national role in this decision-making process. First, a regulator, the Medicines and Healthcare products Regulatory Agency (MHRA), which is akin to the Food and Drug Administration (FDA) in the USA and has statutory responsib ...
|Keywords:||Health service, Public administration|
|Subject(s):||Science & technology management|
|Centre:||Institute for Science, Innovation and Society|
|Date Deposited:||27 Aug 2010 09:04|
|Last Modified:||23 Oct 2015 14:05|
Actions (login required)